Eli Lilly pulls millions in Twitter advertising after fake account debacle — report
Eli Lilly is pulling its millions in ad spending on Twitter after last week’s fake posts debacle, according to a news report.
When an imposter Lilly account with a “verified” blue check mark touted, “We are excited to announce insulin is free now,” it set off a mad scramble inside Lilly to reach Twitter and get the post taken down, according to the Washington Post and its sources inside the pharma. The problem, however, was made even worse when no one at Twitter responded for hours, likely due to new owner Elon Musk’s massive staff layoff.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 154,000+ biopharma pros reading Endpoints daily — and it's free.